Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	high voltage-gated calcium channel activity	CACNA1A CACNA1B CACNB1	3.83e-06	14	45	3	GO:0008331
GeneOntologyMolecularFunction	protein domain specific binding	USP8 CACNB1 LDB1 ATN1 MYO7A NIPBL PICALM SH3BP2 HNRNPK TP53BP2	1.96e-05	875	45	10	GO:0019904
GeneOntologyMolecularFunction	phosphoprotein binding	CACNB1 PLCG2 ZAP70 SH3BP2	1.39e-04	117	45	4	GO:0051219
GeneOntologyMolecularFunction	voltage-gated calcium channel activity	CACNA1A CACNA1B CACNB1	1.52e-04	46	45	3	GO:0005245
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels	CACNA1A CACNA1B	1.77e-04	9	45	2	GO:0099511
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels	CACNA1A CACNA1B	1.77e-04	9	45	2	GO:0099626
GeneOntologyMolecularFunction	phosphotyrosine residue binding	PLCG2 ZAP70 SH3BP2	2.06e-04	51	45	3	GO:0001784
GeneOntologyMolecularFunction	SH3 domain binding	USP8 PICALM SH3BP2 TP53BP2	2.99e-04	143	45	4	GO:0017124
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	PLCG2 ZAP70 SH3BP2	5.05e-04	69	45	3	GO:0045309
GeneOntologyMolecularFunction	lamin binding	PLCB1 HNRNPK	8.29e-04	19	45	2	GO:0005521
GeneOntologyMolecularFunction	phosphatidylinositol phospholipase C activity	PLCB1 PLCG2	1.56e-03	26	45	2	GO:0004435
GeneOntologyMolecularFunction	amyloid-beta binding	CACNA1A CACNA1B PICALM	1.57e-03	102	45	3	GO:0001540
GeneOntologyMolecularFunction	phospholipase C activity	PLCB1 PLCG2	1.94e-03	29	45	2	GO:0004629
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	LRP5 MAFB GATA5 PPP2R5D LDB1 BCL9 MAP2K1 PCBP1 CREB3L4 LMX1B NIPBL HNRNPK STAT6 PYGO1	8.58e-07	1390	45	14	GO:0045944
GeneOntologyBiologicalProcess	central nervous system development	COL4A1 PLCB1 CACNA1A LRP5 MAFB ABR LDB1 ATN1 MAP2K1 LMX1B NIPBL HNRNPK TP53BP2	1.01e-06	1197	45	13	GO:0007417
GeneOntologyBiologicalProcess	head development	COL4A1 ANKRD11 PLCB1 CACNA1A MAFB ABR LDB1 MAP2K1 LMX1B NIPBL HNRNPK	3.26e-06	919	45	11	GO:0060322
GeneOntologyBiologicalProcess	cellular response to oxygen-containing compound	PLCB1 CACNA1A LRP5 USP8 ZNF683 CACNB1 IRS4 PLCG2 GBP4 MAP2K1 HNRNPK DDR2 STAT6	8.45e-06	1450	45	13	GO:1901701
GeneOntologyBiologicalProcess	cerebellum morphogenesis	CACNA1A LDB1 MAP2K1 LMX1B	8.82e-06	60	45	4	GO:0021587
GeneOntologyBiologicalProcess	hindbrain morphogenesis	CACNA1A LDB1 MAP2K1 LMX1B	1.14e-05	64	45	4	GO:0021575
GeneOntologyBiologicalProcess	brain development	COL4A1 PLCB1 CACNA1A MAFB ABR LDB1 MAP2K1 LMX1B NIPBL HNRNPK	1.26e-05	859	45	10	GO:0007420
GeneOntologyBiologicalProcess	embryo development	ANKRD11 PLCB1 LRP5 MAFB ABR LDB1 MAP2K1 MYO7A LMX1B NIPBL PRRC2B TP53BP2	4.15e-05	1437	45	12	GO:0009790
GeneOntologyBiologicalProcess	cerebellar cortex formation	CACNA1A LDB1 MAP2K1	5.54e-05	34	45	3	GO:0021697
GeneOntologyBiologicalProcess	response to nitrogen compound	PLCB1 CACNA1A CACNA1B LRP5 CACNB1 IRS4 PLCG2 MAP2K1 HNRNPK DDR2 STAT6	6.81e-05	1272	45	11	GO:1901698
GeneOntologyBiologicalProcess	response to ionomycin	PLCB1 ZNF683	6.94e-05	6	45	2	GO:1904636
GeneOntologyBiologicalProcess	cellular response to ionomycin	PLCB1 ZNF683	6.94e-05	6	45	2	GO:1904637
GeneOntologyBiologicalProcess	retinal blood vessel morphogenesis	COL4A1 LRP5	6.94e-05	6	45	2	GO:0061304
GeneOntologyBiologicalProcess	hindbrain development	CACNA1A MAFB LDB1 MAP2K1 LMX1B	8.75e-05	208	45	5	GO:0030902
GeneOntologyBiologicalProcess	somatic stem cell population maintenance	LRP5 LDB1 BCL9 NIPBL	8.98e-05	108	45	4	GO:0035019
GeneOntologyBiologicalProcess	synapse organization	COL4A1 CACNA1A GABRG3 LRP5 CACNB1 LMX1B PICALM HNRNPK	1.03e-04	685	45	8	GO:0050808
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	PLCB1 CACNA1B LRP5 USP8 PLCG2 PPP2R5D ABR MAP2K1 PICALM HNRNPK DDR2	1.29e-04	1366	45	11	GO:0051130
GeneOntologyBiologicalProcess	developmental growth	ANKRD11 PLCB1 ATN1 BCL9 LMX1B NIPBL PICALM HNRNPK DDR2	1.30e-04	911	45	9	GO:0048589
GeneOntologyBiologicalProcess	embryonic morphogenesis	LRP5 MAFB ABR LDB1 MAP2K1 MYO7A LMX1B NIPBL	1.36e-04	713	45	8	GO:0048598
GeneOntologyBiologicalProcess	response to peptide hormone	PLCB1 LRP5 IRS4 MAP2K1 HNRNPK DDR2 STAT6	1.38e-04	530	45	7	GO:0043434
GeneOntologyBiologicalProcess	cerebellar cortex morphogenesis	CACNA1A LDB1 MAP2K1	1.57e-04	48	45	3	GO:0021696
GeneOntologyBiologicalProcess	cellular response to peptide hormone stimulus	PLCB1 IRS4 MAP2K1 HNRNPK DDR2 STAT6	1.69e-04	381	45	6	GO:0071375
GeneOntologyBiologicalProcess	cell surface receptor protein tyrosine kinase signaling pathway	COL4A1 PLCB1 IRS4 PPP2R5D MAP2K1 ZAP70 DDR2 STAT6	1.87e-04	747	45	8	GO:0007169
GeneOntologyBiologicalProcess	cellular response to nitrogen compound	PLCB1 CACNA1A CACNB1 IRS4 MAP2K1 HNRNPK DDR2 STAT6	1.96e-04	752	45	8	GO:1901699
GeneOntologyBiologicalProcess	negative regulation of cellular extravasation	PLCB1 ABR	2.07e-04	10	45	2	GO:0002692
GeneOntologyBiologicalProcess	cell junction organization	COL4A1 CACNA1A GABRG3 LRP5 CACNB1 LDB1 LMX1B PICALM HNRNPK	2.15e-04	974	45	9	GO:0034330
GeneOntologyBiologicalProcess	cerebellum development	CACNA1A LDB1 MAP2K1 LMX1B	2.37e-04	139	45	4	GO:0021549
GeneOntologyBiologicalProcess	hemopoiesis	PLCB1 KLF3 ZNF683 MAFB PLCG2 LDB1 PICALM ZAP70 STAT6 PYGO1	2.46e-04	1223	45	10	GO:0030097
GeneOntologyBiologicalProcess	cellular response to ether	PLCB1 ZNF683	2.53e-04	11	45	2	GO:0071362
GeneOntologyBiologicalProcess	retina vasculature morphogenesis in camera-type eye	COL4A1 LRP5	2.53e-04	11	45	2	GO:0061299
GeneOntologyBiologicalProcess	negative regulation of erythrocyte differentiation	MAFB LDB1	2.53e-04	11	45	2	GO:0045647
GeneOntologyBiologicalProcess	growth	ANKRD11 PLCB1 ATN1 BCL9 LMX1B DCBLD2 NIPBL PICALM HNRNPK DDR2	2.66e-04	1235	45	10	GO:0040007
GeneOntologyBiologicalProcess	collagen-activated tyrosine kinase receptor signaling pathway	COL4A1 DDR2	3.03e-04	12	45	2	GO:0038063
GeneOntologyBiologicalProcess	response to amyloid-beta	CACNA1A CACNA1B CACNB1	3.20e-04	61	45	3	GO:1904645
GeneOntologyBiologicalProcess	metencephalon development	CACNA1A LDB1 MAP2K1 LMX1B	3.42e-04	153	45	4	GO:0022037
GeneOntologyBiologicalProcess	ear morphogenesis	MAFB ABR MYO7A NIPBL	3.51e-04	154	45	4	GO:0042471
GeneOntologyBiologicalProcess	face development	ANKRD11 MAP2K1 NIPBL	3.52e-04	63	45	3	GO:0060324
GeneOntologyBiologicalProcess	neuromuscular junction development	COL4A1 LRP5 CACNB1	4.40e-04	68	45	3	GO:0007528
GeneOntologyBiologicalProcess	import into cell	CACNA1A CACNA1B LRP5 SIGLEC1 PLCG2 ABR MYO7A PICALM HNRNPK	4.42e-04	1074	45	9	GO:0098657
GeneOntologyBiologicalProcess	cerebellar cortex development	CACNA1A LDB1 MAP2K1	5.00e-04	71	45	3	GO:0021695
GeneOntologyBiologicalProcess	regulation of vesicle-mediated transport	CACNA1A CACNA1B PLCG2 ABR MAP2K1 PICALM HNRNPK	5.58e-04	667	45	7	GO:0060627
GeneOntologyBiologicalProcess	neuromuscular process controlling balance	CACNA1A ABR MYO7A	5.64e-04	74	45	3	GO:0050885
GeneOntologyBiologicalProcess	inositol trisphosphate metabolic process	PLCB1 PLCG2	6.20e-04	17	45	2	GO:0032957
GeneOntologyBiologicalProcess	response to lipid	PLCB1 CACNA1B USP8 ZNF683 PLCG2 ABR GBP4 MAP2K1 HNRNPK	6.23e-04	1126	45	9	GO:0033993
GeneOntologyBiologicalProcess	collagen-activated signaling pathway	COL4A1 DDR2	6.96e-04	18	45	2	GO:0038065
GeneOntologyBiologicalProcess	cerebellar Purkinje cell differentiation	CACNA1A LDB1	6.96e-04	18	45	2	GO:0021702
GeneOntologyBiologicalProcess	positive regulation of cell cycle G1/S phase transition	PLCB1 PLCG2 DDR2	7.09e-04	80	45	3	GO:1902808
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	PLCB1 CACNA1A CACNA1B GABRG3 USP8 CACNB1 ABR HNRNPK	8.15e-04	931	45	8	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	PLCB1 CACNA1A CACNA1B GABRG3 USP8 CACNB1 ABR HNRNPK	8.15e-04	931	45	8	GO:0007268
GeneOntologyBiologicalProcess	Wnt signaling pathway	LRP5 USP8 PLCG2 LDB1 BCL9 PYGO1	8.47e-04	516	45	6	GO:0016055
GeneOntologyBiologicalProcess	trans-synaptic signaling	PLCB1 CACNA1A CACNA1B GABRG3 USP8 CACNB1 ABR HNRNPK	8.61e-04	939	45	8	GO:0099537
GeneOntologyBiologicalProcess	cerebellar Purkinje cell layer formation	CACNA1A LDB1	8.62e-04	20	45	2	GO:0021694
GeneOntologyBiologicalProcess	sensory organ morphogenesis	LRP5 MAFB ABR MYO7A NIPBL	8.74e-04	343	45	5	GO:0090596
GeneOntologyBiologicalProcess	enzyme-linked receptor protein signaling pathway	COL4A1 PLCB1 IRS4 PPP2R5D BCL9 MAP2K1 ZAP70 DDR2 STAT6	9.03e-04	1186	45	9	GO:0007167
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	PLCB1 USP8 IRS4 MAP2K1 HNRNPK DDR2 STAT6	9.27e-04	727	45	7	GO:0032870
GeneOntologyBiologicalProcess	sensory organ development	COL4A1 LRP5 MAFB ABR MYO7A LMX1B NIPBL	9.50e-04	730	45	7	GO:0007423
GeneOntologyBiologicalProcess	response to ether	PLCB1 ZNF683	1.05e-03	22	45	2	GO:0045472
GeneOntologyBiologicalProcess	synaptic signaling	PLCB1 CACNA1A CACNA1B GABRG3 USP8 CACNB1 ABR HNRNPK	1.11e-03	976	45	8	GO:0099536
GeneOntologyBiologicalProcess	pigment granule transport	MAP2K1 MYO7A	1.14e-03	23	45	2	GO:0051904
GeneOntologyBiologicalProcess	positive regulation of endocytosis	PLCG2 ABR PICALM HNRNPK	1.18e-03	213	45	4	GO:0045807
GeneOntologyBiologicalProcess	phosphatidylinositol-mediated signaling	PLCB1 PLCG2	1.25e-03	24	45	2	GO:0048015
GeneOntologyBiologicalProcess	establishment of pigment granule localization	MAP2K1 MYO7A	1.25e-03	24	45	2	GO:0051905
GeneOntologyBiologicalProcess	calcium ion transmembrane import into cytosol	PLCB1 CACNA1A CACNA1B PLCG2	1.27e-03	217	45	4	GO:0097553
GeneOntologyBiologicalProcess	embryonic organ development	MAFB ABR LDB1 MAP2K1 MYO7A NIPBL	1.30e-03	561	45	6	GO:0048568
GeneOntologyBiologicalProcess	cerebellar Purkinje cell layer morphogenesis	CACNA1A LDB1	1.35e-03	25	45	2	GO:0021692
GeneOntologyBiologicalProcess	positive regulation of Ras protein signal transduction	MAP2K1 PICALM	1.35e-03	25	45	2	GO:0046579
GeneOntologyBiologicalProcess	animal organ morphogenesis	ANKRD11 LRP5 MAFB GATA5 ABR MAP2K1 MYO7A NIPBL STAT6	1.45e-03	1269	45	9	GO:0009887
GeneOntologyBiologicalProcess	pigment granule localization	MAP2K1 MYO7A	1.46e-03	26	45	2	GO:0051875
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	PLCB1 CACNA1A CACNA1B CACNB1 PLCG2	1.58e-03	392	45	5	GO:0070588
GeneOntologyBiologicalProcess	response to hormone	PLCB1 LRP5 USP8 IRS4 MAP2K1 HNRNPK DDR2 STAT6	1.68e-03	1042	45	8	GO:0009725
GeneOntologyBiologicalProcess	stem cell population maintenance	LRP5 LDB1 BCL9 NIPBL	1.75e-03	237	45	4	GO:0019827
GeneOntologyBiologicalProcess	positive regulation of developmental growth	PLCB1 NIPBL PICALM HNRNPK	1.78e-03	238	45	4	GO:0048639
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	KLF3 MAFB GATA5 LDB1 ATN1 NIPBL HNRNPK STAT6	1.80e-03	1053	45	8	GO:0000122
GeneOntologyBiologicalProcess	maintenance of cell number	LRP5 LDB1 BCL9 NIPBL	1.89e-03	242	45	4	GO:0098727
GeneOntologyBiologicalProcess	retina vasculature development in camera-type eye	COL4A1 LRP5	1.95e-03	30	45	2	GO:0061298
GeneOntologyBiologicalProcess	endocytosis	LRP5 SIGLEC1 PLCG2 ABR MYO7A PICALM HNRNPK	1.95e-03	827	45	7	GO:0006897
GeneOntologyBiologicalProcess	regulation of neuron projection development	CACNA1A PPP2R5D MAP2K1 PICALM HNRNPK DDR2	2.03e-03	612	45	6	GO:0010975
GeneOntologyBiologicalProcess	immune system development	LRP5 MAFB MAP2K1 STAT6	2.06e-03	248	45	4	GO:0002520
GeneOntologyBiologicalProcess	positive regulation of dendrite extension	PICALM HNRNPK	2.08e-03	31	45	2	GO:1903861
GeneOntologyBiologicalProcess	cognition	ANKRD11 PLCB1 LMX1B NIPBL PICALM	2.20e-03	423	45	5	GO:0050890
GeneOntologyBiologicalProcess	cell differentiation in hindbrain	CACNA1A LDB1	2.21e-03	32	45	2	GO:0021533
GeneOntologyCellularComponent	postsynapse	PLCB1 CACNA1A GABRG3 USP8 CACNB1 ABR MAP2K1 PCBP1 PICALM HNRNPK	3.92e-05	1018	44	10	GO:0098794
GeneOntologyCellularComponent	voltage-gated calcium channel complex	CACNA1A CACNA1B CACNB1	1.24e-04	46	44	3	GO:0005891
GeneOntologyCellularComponent	chromatin	ANKRD11 PLCB1 KLF3 MAFB GATA5 LDB1 CREB3L4 LMX1B NIPBL HNRNPK STAT6	1.87e-04	1480	44	11	GO:0000785
GeneOntologyCellularComponent	glutamatergic synapse	PLCB1 CACNA1A CACNA1B USP8 CACNB1 ABR MAP2K1 HNRNPK	2.67e-04	817	44	8	GO:0098978
GeneOntologyCellularComponent	beta-catenin-TCF complex	LDB1 BCL9	3.33e-04	13	44	2	GO:1990907
GeneOntologyCellularComponent	calcium channel complex	CACNA1A CACNA1B CACNB1	4.88e-04	73	44	3	GO:0034704
HumanPheno	Hypoplastic radial head	LMX1B NIPBL	2.13e-05	2	24	2	HP:0003997
HumanPheno	Abnormal cheek morphology	ANKRD11 LRP5 MAFB GATA5 MAP2K1 LMX1B SH3BP2 HNRNPK	2.70e-05	282	24	8	HP:0004426
HumanPheno	Inability to walk	SLC19A3 PLCB1 CACNA1A CACNA1B LRP5 MAFB ATN1 LMX1B HNRNPK	3.45e-05	385	24	9	HP:0002540
MousePheno	abnormal neurocranium morphology	ANKRD11 LRP5 MAFB LMX1B NIPBL SH3BP2 PRRC2B DDR2	7.64e-07	269	40	8	MP:0000074
MousePheno	abnormal cranium morphology	ANKRD11 PLCB1 LRP5 MAFB MAP2K1 LMX1B NIPBL SH3BP2 PRRC2B TP53BP2 DDR2	1.17e-05	813	40	11	MP:0000438
MousePheno	abnormal craniofacial bone morphology	ANKRD11 PLCB1 LRP5 MAFB MAP2K1 LMX1B NIPBL SH3BP2 PRRC2B TP53BP2 DDR2	1.38e-05	827	40	11	MP:0002116
MousePheno	abnormal rhombomere morphology	MAFB LDB1 LMX1B	1.44e-05	17	40	3	MP:0000933
MousePheno	abnormal neuromere morphology	MAFB LDB1 LMX1B	1.72e-05	18	40	3	MP:0003208
MousePheno	postnatal lethality	COL4A1 PLCB1 CACNA1A CACNA1B LRP5 KLF3 MAFB PPP2R5D ATN1 NIPBL PICALM TP53BP2	3.23e-05	1084	40	12	MP:0002082
MousePheno	buphthalmos	COL4A1 LMX1B	4.77e-05	4	40	2	MP:0009274
MousePheno	absent midbrain-hindbrain boundary	LDB1 LMX1B	4.77e-05	4	40	2	MP:0012133
MousePheno	increased B cell apoptosis	PLCG2 SH3BP2 STAT6	6.77e-05	28	40	3	MP:0008782
MousePheno	abnormal axial skeleton morphology	ANKRD11 PLCB1 LRP5 CACNB1 MAFB MAP2K1 LMX1B DCBLD2 NIPBL SH3BP2 PRRC2B TP53BP2 DDR2	1.32e-04	1458	40	13	MP:0002114
MousePheno	small face	ANKRD11 NIPBL DDR2	1.58e-04	37	40	3	MP:0030064
MousePheno	abnormal cranium size	ANKRD11 PLCB1 MAP2K1 DDR2	1.64e-04	97	40	4	MP:0010031
MousePheno	abnormal rhombomere 5 morphology	MAFB LDB1	1.66e-04	7	40	2	MP:0012800
MousePheno	abnormal nephron morphology	SLC19A3 COL4A1 MAFB GATA5 PLCG2 LMX1B STAT6	1.81e-04	426	40	7	MP:0003881
MousePheno	macrophthalmia	COL4A1 LMX1B	2.21e-04	8	40	2	MP:0001296
MousePheno	abnormal face size	ANKRD11 NIPBL DDR2	2.31e-04	42	40	3	MP:0030063
MousePheno	abnormal craniofacial morphology	ANKRD11 PLCB1 LRP5 MAFB LDB1 MAP2K1 LMX1B NIPBL SH3BP2 PRRC2B TP53BP2 DDR2	3.13e-04	1372	40	12	MP:0000428
MousePheno	craniofacial phenotype	ANKRD11 PLCB1 LRP5 MAFB LDB1 MAP2K1 LMX1B NIPBL SH3BP2 PRRC2B TP53BP2 DDR2	3.13e-04	1372	40	12	MP:0005382
MousePheno	decreased IgM level	SIGLEC1 PLCG2 SH3BP2 STAT6	3.16e-04	115	40	4	MP:0001806
MousePheno	abnormal B cell apoptosis	PLCG2 SH3BP2 STAT6	3.23e-04	47	40	3	MP:0008781
MousePheno	circling	CACNA1A MAFB MYO7A NIPBL	3.38e-04	117	40	4	MP:0001394
MousePheno	abnormal cardiovascular development	LRP5 KLF3 USP8 GATA5 LDB1 MAP2K1 DCBLD2 PRRC2B TP53BP2	3.52e-04	802	40	9	MP:0002925
MousePheno	increased heart right atrium size	KLF3 GATA5	3.54e-04	10	40	2	MP:0008727
MousePheno	impaired macrophage phagocytosis	SIGLEC1 PLCG2 SH3BP2	3.88e-04	50	40	3	MP:0001798
MousePheno	decreased collagen level	COL4A1 DDR2	4.32e-04	11	40	2	MP:0020254
MousePheno	reduced male fertility	PLCB1 CACNA1A MAFB ATN1 MYO7A DDR2	4.55e-04	352	40	6	MP:0001922
MousePheno	abnormal osteoclast cell number	ANKRD11 LRP5 PLCG2 SH3BP2	4.75e-04	128	40	4	MP:0004983
MousePheno	abnormal heart atrium size	KLF3 GATA5 NIPBL	4.87e-04	54	40	3	MP:0031576
MousePheno	reduced fertility	COL4A1 PLCB1 CACNA1A MAFB GATA5 IRS4 ATN1 MYO7A DDR2	5.12e-04	844	40	9	MP:0001921
MousePheno	abnormal podocyte foot process morphology	COL4A1 MAFB LMX1B	5.14e-04	55	40	3	MP:0008059
MousePheno	abnormal blood circulation	COL4A1 LRP5 KLF3 MAFB GATA5 PLCG2 DCBLD2 PRRC2B TP53BP2	5.16e-04	845	40	9	MP:0002128
MousePheno	vascular stenosis	GATA5 MAP2K1 TP53BP2	5.42e-04	56	40	3	MP:0005412
MousePheno	decreased osteoclast cell number	ANKRD11 LRP5 PLCG2	6.01e-04	58	40	3	MP:0004985
MousePheno	abnormal midbrain-hindbrain boundary morphology	LDB1 LMX1B	8.19e-04	15	40	2	MP:0012132
Domain	PH_dom-like	PLCB1 IRS4 PLCG2 PTPN21 ABR MYO7A SH3BP2	6.56e-05	426	45	7	IPR011993
Domain	SH2	PLCG2 ZAP70 SH3BP2 STAT6	1.01e-04	101	45	4	PF00017
Domain	VDCC_a1su_IQ	CACNA1A CACNA1B	1.18e-04	7	45	2	IPR014873
Domain	GPHH	CACNA1A CACNA1B	1.18e-04	7	45	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1B	1.18e-04	7	45	2	IPR031649
Domain	Ca_chan_IQ	CACNA1A CACNA1B	1.18e-04	7	45	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1B	1.18e-04	7	45	2	PF08763
Domain	SH2	PLCG2 ZAP70 SH3BP2 STAT6	1.41e-04	110	45	4	SM00252
Domain	SH2	PLCG2 ZAP70 SH3BP2 STAT6	1.46e-04	111	45	4	PS50001
Domain	SH2	PLCG2 ZAP70 SH3BP2 STAT6	1.51e-04	112	45	4	IPR000980
Domain	-	PLCG2 ZAP70 SH3BP2 STAT6	1.51e-04	112	45	4	3.30.505.10
Domain	VDCCAlpha1	CACNA1A CACNA1B	2.52e-04	10	45	2	IPR002077
Domain	-	IRS4 PLCG2 PTPN21 ABR MYO7A SH3BP2	3.31e-04	391	45	6	2.30.29.30
Domain	PLipase_C_Pinositol-sp_Y	PLCB1 PLCG2	5.84e-04	15	45	2	IPR001711
Domain	EF-hand_like	PLCB1 PLCG2	5.84e-04	15	45	2	PF09279
Domain	PIPLC_Y_DOMAIN	PLCB1 PLCG2	5.84e-04	15	45	2	PS50008
Domain	PI-PLC_fam	PLCB1 PLCG2	5.84e-04	15	45	2	IPR001192
Domain	PLC_EF-hand-like	PLCB1 PLCG2	5.84e-04	15	45	2	IPR015359
Domain	PI-PLC-Y	PLCB1 PLCG2	5.84e-04	15	45	2	PF00387
Domain	PLCYc	PLCB1 PLCG2	5.84e-04	15	45	2	SM00149
Domain	PI-PLC-X	PLCB1 PLCG2	8.47e-04	18	45	2	PF00388
Domain	PLCXc	PLCB1 PLCG2	8.47e-04	18	45	2	SM00148
Domain	PIPLC_X_DOMAIN	PLCB1 PLCG2	9.46e-04	19	45	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCB1 PLCG2	9.46e-04	19	45	2	IPR000909
Domain	FA58C	DCBLD2 DDR2	1.16e-03	21	45	2	SM00231
Domain	FA58C_3	DCBLD2 DDR2	1.16e-03	21	45	2	PS50022
Domain	FA58C_1	DCBLD2 DDR2	1.16e-03	21	45	2	PS01285
Domain	FA58C_2	DCBLD2 DDR2	1.16e-03	21	45	2	PS01286
Domain	F5_F8_type_C	DCBLD2 DDR2	1.51e-03	24	45	2	PF00754
Domain	FA58C	DCBLD2 DDR2	1.51e-03	24	45	2	IPR000421
Domain	-	PLCB1 PLCG2	1.64e-03	25	45	2	3.20.20.190
Domain	PLC-like_Pdiesterase_TIM-brl	PLCB1 PLCG2	1.64e-03	25	45	2	IPR017946
Domain	SH3	CACNB1 PLCG2 MYO7A TP53BP2	1.79e-03	216	45	4	SM00326
Domain	SH3	CACNB1 PLCG2 MYO7A TP53BP2	1.79e-03	216	45	4	PS50002
Domain	SH3_domain	CACNB1 PLCG2 MYO7A TP53BP2	1.91e-03	220	45	4	IPR001452
Domain	FERM_N	PTPN21 MYO7A	2.86e-03	33	45	2	PF09379
Domain	FERM_N	PTPN21 MYO7A	2.86e-03	33	45	2	IPR018979
Domain	TF_DNA-bd	MAFB CREB3L4	3.58e-03	37	45	2	IPR008917
Domain	KH_1	PCBP1 HNRNPK	3.78e-03	38	45	2	PF00013
Domain	C2	PLCB1 PLCG2 ABR	3.86e-03	131	45	3	PF00168
Domain	-	PCBP1 HNRNPK	3.97e-03	39	45	2	3.30.1370.10
Domain	KH	PCBP1 HNRNPK	4.18e-03	40	45	2	SM00322
Domain	KH_dom	PCBP1 HNRNPK	4.18e-03	40	45	2	IPR004087
Domain	C2	PLCB1 PLCG2 ABR	4.37e-03	137	45	3	SM00239
Domain	PH	IRS4 PLCG2 ABR SH3BP2	4.43e-03	278	45	4	SM00233
Domain	PH_DOMAIN	IRS4 PLCG2 ABR SH3BP2	4.49e-03	279	45	4	PS50003
Domain	PH_domain	IRS4 PLCG2 ABR SH3BP2	4.55e-03	280	45	4	IPR001849
Domain	KH_TYPE_1	PCBP1 HNRNPK	4.60e-03	42	45	2	PS50084
Domain	C2	PLCB1 PLCG2 ABR	4.83e-03	142	45	3	PS50004
Domain	EF-hand-dom_pair	PLCB1 CACNA1B PLCG2 STAT6	4.96e-03	287	45	4	IPR011992
Domain	KH_dom_type_1	PCBP1 HNRNPK	5.04e-03	44	45	2	IPR004088
Domain	-	PLCB1 PLCG2 ABR	5.42e-03	148	45	3	2.60.40.150
Domain	FERM_M	PTPN21 MYO7A	5.49e-03	46	45	2	PF00373
Domain	-	PTPN21 MYO7A	6.21e-03	49	45	2	1.20.80.10
Domain	FERM_central	PTPN21 MYO7A	6.21e-03	49	45	2	IPR019748
Domain	FERM_domain	PTPN21 MYO7A	6.21e-03	49	45	2	IPR000299
Domain	FERM_1	PTPN21 MYO7A	6.46e-03	50	45	2	PS00660
Domain	FERM_2	PTPN21 MYO7A	6.46e-03	50	45	2	PS00661
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNA1A CACNA1B CACNB1	3.18e-06	11	39	3	MM14498
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNA1A CACNA1B CACNB1	3.18e-06	11	39	3	M26913
Pathway	KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY	PLCB1 PLCG2 MAP2K1	1.84e-05	19	39	3	M47596
Pathway	KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL	CACNA1A CACNA1B CACNB1	4.32e-05	25	39	3	M47948
Pathway	REACTOME_SIGNALING_BY_WNT	PLCB1 LRP5 USP8 PPP2R5D BCL9 PYGO1	4.55e-05	239	39	6	MM14756
Pathway	WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA	LRP5 BCL9 PYGO1	4.87e-05	26	39	3	M39407
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	LRP5 USP8 PPP2R5D BCL9 PYGO1	7.03e-05	158	39	5	MM14791
Pathway	PID_AR_NONGENOMIC_PATHWAY	PLCB1 PLCG2 MAP2K1	8.34e-05	31	39	3	M213
Pathway	REACTOME_SIGNALING_BY_WNT	PLCB1 LRP5 USP8 PPP2R5D BCL9 PYGO1	2.67e-04	330	39	6	M7847
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	PLCB1 CACNA1A CACNA1B GABRG3 CACNB1	2.73e-04	211	39	5	MM14502
Pathway	KEGG_TYPE_II_DIABETES_MELLITUS	CACNA1A CACNA1B IRS4	2.92e-04	47	39	3	M19708
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	CACNA1A CACNA1B	4.04e-04	11	39	2	M47958
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	LRP5 USP8 PPP2R5D BCL9 PYGO1	4.30e-04	233	39	5	M27099
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	PLCG2 MAP2K1 ZAP70 SH3BP2	5.39e-04	137	39	4	M5669
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	COL4A1 GABRG3 USP8 IRS4 PPP2R5D MAP2K1 STAT6	5.64e-04	532	39	7	M27870
Pathway	BIOCARTA_BARR_MAPK_PATHWAY	PLCB1 MAP2K1	6.65e-04	14	39	2	M668
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY	PLCG2 MAP2K1	6.65e-04	14	39	2	M47383
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY	PLCG2 MAP2K1	6.65e-04	14	39	2	M47384
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS	TP53BP2 BANP	6.65e-04	14	39	2	MM15341
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS	TP53BP2 BANP	6.65e-04	14	39	2	M27638
Pathway	BIOCARTA_BARR_MAPK_PATHWAY	PLCB1 MAP2K1	6.65e-04	14	39	2	MM1489
Pathway	BIOCARTA_CDMAC_PATHWAY	PLCB1 MAP2K1	7.65e-04	15	39	2	MM1358
Pathway	WP_GPR40_PATHWAY	PLCB1 PLCG2	7.65e-04	15	39	2	M39526
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	PLCG2 MAP2K1	7.65e-04	15	39	2	M47382
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	PLCB1 CACNA1A CACNA1B GABRG3 CACNB1	8.39e-04	270	39	5	M15514
Pathway	BIOCARTA_SPPA_PATHWAY	PLCB1 MAP2K1	8.73e-04	16	39	2	M8731
Pathway	BIOCARTA_CDMAC_PATHWAY	PLCB1 MAP2K1	8.73e-04	16	39	2	M4388
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	COL4A1 USP8 IRS4 PPP2R5D MAP2K1 STAT6	9.33e-04	418	39	6	MM15587
Pathway	KEGG_LONG_TERM_DEPRESSION	PLCB1 CACNA1A MAP2K1	9.43e-04	70	39	3	M8232
Pathway	BIOCARTA_BARRESTIN_SRC_PATHWAY	PLCB1 MAP2K1	9.88e-04	17	39	2	M111
Pathway	BIOCARTA_BARRESTIN_SRC_PATHWAY	PLCB1 MAP2K1	9.88e-04	17	39	2	MM1491
Pathway	WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL	CACNA1A CACNA1B CACNB1	1.07e-03	73	39	3	MM16641
Pathway	BIOCARTA_CCR3_PATHWAY	PLCB1 MAP2K1	1.24e-03	19	39	2	MM1361
Pathway	KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY	PLCG2 ZAP70	1.24e-03	19	39	2	M47733
Pathway	BIOCARTA_CCR3_PATHWAY	PLCB1 MAP2K1	1.24e-03	19	39	2	M9152
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	LRP5 USP8	1.37e-03	20	39	2	MM15155
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	COL4A1 IRS4 PPP2R5D MAP2K1 CREB3L4	1.38e-03	302	39	5	M39719
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	PLCB1 CACNA1A CACNA1B PLCG2	1.43e-03	178	39	4	M2890
Pathway	KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY	MAP2K1 CREB3L4	1.52e-03	21	39	2	M47792
Pathway	KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY	PLCB1 MAP2K1	1.52e-03	21	39	2	M47638
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	LRP5 USP8	1.52e-03	21	39	2	M27401
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY	PLCB1 PLCG2	1.52e-03	21	39	2	M47542
Pathway	WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA	PLCB1 CACNA1A	1.66e-03	22	39	2	M39795
Pathway	KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY	MAP2K1 CREB3L4	1.82e-03	23	39	2	M47799
Pathway	KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1A CACNA1B	1.82e-03	23	39	2	M47666
Pathway	WNT_SIGNALING	LRP5 BCL9 PYGO1	1.89e-03	89	39	3	M5493
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	COL4A1 IRS4 PPP2R5D MAP2K1 CREB3L4	1.94e-03	326	39	5	MM15917
Pathway	REACTOME_NEURONAL_SYSTEM	PLCB1 CACNA1A CACNA1B GABRG3 CACNB1	2.18e-03	335	39	5	MM14503
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 PLCG2	2.32e-03	26	39	2	M27483
Pathway	REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL	PLCB1 PLCG2	2.32e-03	26	39	2	M27053
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9 PYGO1	2.32e-03	26	39	2	MM14793
Pathway	WP_B_CELL_RECEPTOR_SIGNALING	PLCG2 MAP2K1 SH3BP2	2.41e-03	97	39	3	M39323
Pathway	WP_CANCER_PATHWAYS	COL4A1 PLCB1 LRP5 PLCG2 MAP2K1 STAT6	2.50e-03	507	39	6	M48302
Pathway	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	PLCG2 ZAP70	2.51e-03	27	39	2	MM14809
Pathway	REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL	PLCB1 PLCG2	2.69e-03	28	39	2	MM14711
Pathway	KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY	PLCB1 CREB3L4	2.69e-03	28	39	2	M47508
Pathway	KEGG_MELANOGENESIS	PLCB1 MAP2K1 CREB3L4	2.71e-03	101	39	3	M7761
Pathway	WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME	BCL9 PYGO1	2.89e-03	29	39	2	M39890
Pathway	WP_PDGFRBETA_PATHWAY	MAP2K1 STAT6	2.89e-03	29	39	2	M39616
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PLCB1 CACNA1A CACNB1 PPP2R5D ABR LDB1 BCL9 PCBP1 NIPBL PICALM HNRNPK PRRC2B TP53BP2	1.67e-10	963	45	13	28671696
Pubmed	beta subunit reshuffling modifies N- and P/Q-type Ca2+ channel subunit compositions in lethargic mouse brain.	CACNA1A CACNA1B CACNB1	4.04e-08	6	45	3	10328888
Pubmed	Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.	PLCG2 ZAP70 SH3BP2	1.13e-07	8	45	3	11390470
Pubmed	Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.	CACNA1A CACNA1B CACNB1	9.11e-07	15	45	3	20188150
Pubmed	Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.	CACNA1A CACNA1B CACNB1	9.11e-07	15	45	3	24453333
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	PLCB1 MUC16 USP8 DNAH12 BCL9 MYO7A NIPBL PRRC2B	1.45e-06	638	45	8	31182584
Pubmed	Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels.	CACNA1A CACNA1B	1.64e-06	2	45	2	23426690
Pubmed	A dominant-negative mutation of mouse Lmx1b causes glaucoma and is semi-lethal via LDB1-mediated dimerization [corrected].	LDB1 LMX1B	1.64e-06	2	45	2	24809698
Pubmed	Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers.	CACNA1A CACNA1B	1.64e-06	2	45	2	23376566
Pubmed	Novel Cav2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current.	CACNA1A CACNB1	1.64e-06	2	45	2	11756409
Pubmed	Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K.	PCBP1 HNRNPK	1.64e-06	2	45	2	8152927
Pubmed	Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex.	BCL9 PYGO1	1.64e-06	2	45	2	18498752
Pubmed	CaV 2.1 α1 subunit motifs that control presynaptic CaV 2.1 subtype abundance are distinct from CaV 2.1 preference.	CACNA1A CACNA1B	1.64e-06	2	45	2	38155373
Pubmed	Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel.	CACNA1A CACNB1	1.64e-06	2	45	2	1370480
Pubmed	Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome.	LDB1 LMX1B	1.64e-06	2	45	2	12792813
Pubmed	LMX1B transactivation and expression in nail-patella syndrome.	LDB1 LMX1B	1.64e-06	2	45	2	10767331
Pubmed	Expression analysis of P/Q-type Ca2+ channel alpha 1A subunit mRNA in olfactory mitral cell in N-type Ca2+ channel alpha 1B subunit gene-deficient mice.	CACNA1A CACNA1B	1.64e-06	2	45	2	15050706
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	USP8 IRS4 AFTPH PCBP1 NIPBL PICALM HNRNPK PRRC2B TP53BP2	2.60e-06	934	45	9	33916271
Pubmed	Pygopus residues required for its binding to Legless are critical for transcription and development.	BCL9 PYGO1	4.91e-06	3	45	2	14612447
Pubmed	Munc13-3 Is Required for the Developmental Localization of Ca2+ Channels to Active Zones and the Nanopositioning of Cav2.1 Near Release Sensors.	CACNA1A CACNA1B	4.91e-06	3	45	2	29466725
Pubmed	Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting.	CACNA1A CACNA1B	4.91e-06	3	45	2	24394417
Pubmed	The intracellular C-terminus confers compartment-specific targeting of voltage-gated calcium channels.	CACNA1A CACNA1B	4.91e-06	3	45	2	38996073
Pubmed	The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes.	LDB1 LMX1B	4.91e-06	3	45	2	17316599
Pubmed	MEK1/2 Inhibition Promotes Macrophage Reparative Properties.	MAP2K1 STAT6	4.91e-06	3	45	2	28003382
Pubmed	SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.	PLCG2 SH3BP2	4.91e-06	3	45	2	20872577
Pubmed	Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1.	PCBP1 HNRNPK	4.91e-06	3	45	2	27292014
Pubmed	Assignment of human KH-box-containing genes by in situ hybridization: HNRNPK maps to 9q21.32-q21.33, PCBP1 to 2p12-p13, and PCBP2 to 12q13.12-q13.13, distal to FRA12A.	PCBP1 HNRNPK	4.91e-06	3	45	2	8833161
Pubmed	Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.	CACNA1A CACNA1B	4.91e-06	3	45	2	24523520
Pubmed	Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels.	CACNA1A CACNA1B	4.91e-06	3	45	2	29208674
Pubmed	Molecular architecture of CAG repeats in human disease related transcripts.	CACNA1A ATN1	4.91e-06	3	45	2	15223312
Pubmed	Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.	CACNA1A CACNA1B	4.91e-06	3	45	2	26507659
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	ABR BCL9 NIPBL PRRC2B	5.76e-06	90	45	4	15033168
Pubmed	A quantitative protein interaction network for the ErbB receptors using protein microarrays.	IRS4 PLCG2 ZAP70 SH3BP2	5.76e-06	90	45	4	16273093
Pubmed	Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.	LRP5 PPP2R5D BCL9 PYGO1	5.76e-06	90	45	4	19515997
Pubmed	Interaction network of human early embryonic transcription factors.	KLF3 LDB1 ATN1 BCL9 NIPBL PRRC2B	5.92e-06	351	45	6	38297188
Pubmed	Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.	BCL9 PCBP1 HNRNPK	9.78e-06	32	45	3	24706805
Pubmed	Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry.	CACNA1A CACNA1B	9.81e-06	4	45	2	32616470
Pubmed	Constitutive and ghrelin-dependent GHSR1a activation impairs CaV2.1 and CaV2.2 currents in hypothalamic neurons.	CACNA1A CACNA1B	9.81e-06	4	45	2	26283199
Pubmed	A strategy for fine-structure functional analysis of a 6- to 11-centimorgan region of mouse chromosome 7 by high-efficiency mutagenesis.	MYO7A PICALM	9.81e-06	4	45	2	2300582
Pubmed	The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages.	MAFB STAT6	9.81e-06	4	45	2	28790455
Pubmed	A protein phosphatase 2calpha-Ca2+ channel complex for dephosphorylation of neuronal Ca2+ channels phosphorylated by protein kinase C.	CACNA1A CACNA1B	9.81e-06	4	45	2	15728831
Pubmed	CNS expression pattern of Lmx1b and coexpression with ptx genes suggest functional cooperativity in the development of forebrain motor control systems.	LDB1 LMX1B	9.81e-06	4	45	2	12498783
Pubmed	53BP2S, interacting with insulin receptor substrates, modulates insulin signaling.	IRS4 TP53BP2	9.81e-06	4	45	2	17965023
Pubmed	The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels.	CACNA1A CACNA1B	9.81e-06	4	45	2	25483588
Pubmed	Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.	BCL9 PYGO1	9.81e-06	4	45	2	11955446
Pubmed	Cerebellar granule cell signaling is indispensable for normal motor performance.	CACNA1A CACNA1B	9.81e-06	4	45	2	37141091
Pubmed	Interactions of Rabconnectin-3 with Cav2 calcium channels.	CACNA1A CACNA1B	9.81e-06	4	45	2	31253182
Pubmed	G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels.	CACNA1A CACNA1B	9.81e-06	4	45	2	15953418
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKRD11 LRP5 EML2 ABR BCL9 MYO7A LMX1B PRRC2B BANP	1.01e-05	1105	45	9	35748872
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	CACNB1 LDB1 ATN1 PCBP1 HNRNPK PRRC2B TP53BP2	1.23e-05	608	45	7	16713569
Pubmed	Ion channel expression in the developing enteric nervous system.	CACNA1A CACNA1B CACNB1	1.52e-05	37	45	3	25798587
Pubmed	Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits.	CACNA1A CACNA1B	1.63e-05	5	45	2	8825650
Pubmed	Identification of a cardiac isoform of the murine calcium channel alpha1C (Cav1.2-a) subunit and its preferential binding with the beta2 subunit.	CACNA1A CACNA1B	1.63e-05	5	45	2	16787652
Pubmed	TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex.	BCL9 PYGO1	1.63e-05	5	45	2	32808927
Pubmed	Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.	CACNA1A CACNA1B	1.63e-05	5	45	2	15451373
Pubmed	Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.	BCL9 PYGO1	1.63e-05	5	45	2	30760710
Pubmed	Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.	CACNA1A CACNA1B	1.63e-05	5	45	2	11296258
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1A CACNA1B CACNB1	1.65e-05	38	45	3	30786075
Pubmed	Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha.	PLCB1 PLCG2 MAP2K1	1.65e-05	38	45	3	12482669
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	IRS4 AFTPH ATN1 BCL9 PICALM TP53BP2	1.87e-05	430	45	6	35044719
Pubmed	Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse.	CACNA1B CACNB1	2.45e-05	6	45	2	16029198
Pubmed	Expression and immunohistochemical localization of eight phospholipase C isoforms in adult male mouse cerebellar cortex.	PLCB1 PLCG2	2.45e-05	6	45	2	8739298
Pubmed	RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis.	PCBP1 HNRNPK	2.45e-05	6	45	2	15514164
Pubmed	An action potential initiation mechanism in distal axons for the control of dopamine release.	CACNA1A CACNA1B	2.45e-05	6	45	2	35324301
Pubmed	Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity.	BCL9 PYGO1	2.45e-05	6	45	2	21399610
Pubmed	Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.	CACNA1A CACNA1B	2.45e-05	6	45	2	12827191
Pubmed	Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets.	PLCB1 PLCG2	2.45e-05	6	45	2	2841328
Pubmed	Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.	BCL9 PYGO1	2.45e-05	6	45	2	15574752
Pubmed	Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.	LRP5 PLCG2	2.45e-05	6	45	2	27045006
Pubmed	Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.	BCL9 PYGO1	2.45e-05	6	45	2	25184676
Pubmed	A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes.	CACNA1A CACNB1	2.45e-05	6	45	2	21883149
Pubmed	Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors.	CACNA1A CACNA1B	2.45e-05	6	45	2	9238069
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	LDB1 ATN1 BCL9 NIPBL PRRC2B	2.49e-05	268	45	5	33640491
Pubmed	Islet α-, β-, and δ-cell development is controlled by the Ldb1 coregulator, acting primarily with the islet-1 transcription factor.	MAFB LDB1 LMX1B	2.76e-05	45	45	3	23193182
Pubmed	Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.	ZAP70 STAT6	3.42e-05	7	45	2	20118929
Pubmed	Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling.	BCL9 PYGO1	3.42e-05	7	45	2	30366904
Pubmed	Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease.	CACNA1A ATN1	3.42e-05	7	45	2	14756671
Pubmed	Rebuilding essential active zone functions within a synapse.	CACNA1A CACNA1B	3.42e-05	7	45	2	35176221
Pubmed	Fate-mapping analysis of cochlear cells expressing Atoh1 mRNA via a new Atoh13*HA-P2A-Cre knockin mouse strain.	MAFB MYO7A	3.42e-05	7	45	2	35038200
Pubmed	Direct evidence for the action of phosphatidylinositol (3,4,5)-trisphosphate-mediated signal transduction in the 2-cell mouse embryo.	PLCB1 PLCG2	3.42e-05	7	45	2	17634444
Pubmed	Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.	LRP5 MAP2K1	3.42e-05	7	45	2	23945236
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	LDB1 ATN1 BCL9 PRRC2B	4.54e-05	152	45	4	38360978
Pubmed	N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations.	MYO7A PICALM	4.56e-05	8	45	2	10224267
Pubmed	Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.	ZAP70 SH3BP2	4.56e-05	8	45	2	9846481
Pubmed	The protein phosphatase 2A regulatory subunits B'beta and B'delta mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation.	PPP2R5D MAP2K1	4.56e-05	8	45	2	19029245
Pubmed	Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.	LDB1 BCL9	4.56e-05	8	45	2	28296634
Pubmed	Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.	PCBP1 HNRNPK	4.56e-05	8	45	2	19808671
Pubmed	Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line.	PLCB1 PLCG2	5.86e-05	9	45	2	7589147
Pubmed	The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.	USP8 IRS4	5.86e-05	9	45	2	28973533
Pubmed	International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.	CACNA1A CACNA1B	5.86e-05	9	45	2	16382099
Pubmed	Genetics of dizziness: cerebellar and vestibular disorders.	CACNA1A MYO7A	5.86e-05	9	45	2	24275721
Pubmed	Lmx1a and Lmx1b are Redundantly Required for the Development of Multiple Components of the Mammalian Auditory System.	MYO7A LMX1B	5.86e-05	9	45	2	33246067
Pubmed	Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.	PPP2R5D MAP2K1	5.86e-05	9	45	2	16239230
Pubmed	Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat.	PLCB1 PLCG2	5.86e-05	9	45	2	10501179
Pubmed	Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors.	CACNA1A KLF3 MAFB	6.58e-05	60	45	3	32027825
Pubmed	Novel ENU-induced eye mutations in the mouse: models for human eye disease.	COL4A1 LMX1B	7.32e-05	10	45	2	11929848
Pubmed	Expression of phospholipase C isozymes by murine B lymphocytes.	PLCB1 PLCG2	7.32e-05	10	45	2	2033248
Pubmed	Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia.	CACNA1A ATN1	7.32e-05	10	45	2	19235102
Pubmed	Human transcription factor protein interaction networks.	KLF3 IRS4 LDB1 ATN1 BCL9 NIPBL PRRC2B BANP PYGO1	7.57e-05	1429	45	9	35140242
Pubmed	USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.	BCL9 PYGO1	8.94e-05	11	45	2	31073027
Interaction	LHX8 interactions	KLF3 PLCG2 LDB1 BCL9 BANP PYGO1	1.86e-09	53	45	6	int:LHX8
Interaction	ISL1 interactions	MAFB PLCG2 LDB1 BCL9 PYGO1	3.12e-08	41	45	5	int:ISL1
Interaction	CACNB1 interactions	CACNA1A CACNA1B CACNB1 ATN1	2.65e-07	25	45	4	int:CACNB1
Interaction	CRX interactions	LDB1 ATN1 BCL9 NIPBL PICALM PRRC2B BANP	1.40e-06	254	45	7	int:CRX
Interaction	ISL2 interactions	LDB1 BCL9 LMX1B PYGO1	2.07e-06	41	45	4	int:ISL2
Interaction	LHX6 interactions	KLF3 LDB1 BCL9 LMX1B	8.43e-06	58	45	4	int:LHX6
Interaction	SSBP4 interactions	LDB1 BCL9 LMX1B PYGO1	9.02e-06	59	45	4	int:SSBP4
Interaction	CACNB2 interactions	CACNA1A CACNA1B CACNB1	1.79e-05	23	45	3	int:CACNB2
Interaction	TSPOAP1 interactions	ANKRD11 CACNA1A PPP2R5D	2.31e-05	25	45	3	int:TSPOAP1
Interaction	WWP1 interactions	PTPN21 ATN1 PCBP1 HNRNPK TP53BP2 STAT6	2.33e-05	260	45	6	int:WWP1
Interaction	PLCG1 interactions	IRS4 PLCG2 PICALM ZAP70 SH3BP2 HNRNPK	2.53e-05	264	45	6	int:PLCG1
Interaction	LMO4 interactions	LDB1 BCL9 TP53BP2 BANP PYGO1	2.72e-05	159	45	5	int:LMO4
Interaction	PYGO1 interactions	LDB1 BCL9 PYGO1	3.28e-05	28	45	3	int:PYGO1
Interaction	LHX4 interactions	LDB1 BCL9 TP53BP2 BANP PYGO1	3.34e-05	166	45	5	int:LHX4
Interaction	IRF4 interactions	LDB1 NIPBL PRRC2B STAT6	3.85e-05	85	45	4	int:IRF4
Interaction	EGR2 interactions	LDB1 ATN1 BCL9 NIPBL PRRC2B	3.85e-05	171	45	5	int:EGR2
Interaction	TLX1 interactions	LDB1 ATN1 BCL9 NIPBL PYGO1	4.30e-05	175	45	5	int:TLX1
Interaction	CACNB3 interactions	CACNA1A CACNA1B CACNB1	4.93e-05	32	45	3	int:CACNB3
Interaction	NOTO interactions	ANKRD11 HNRNPK BANP	5.42e-05	33	45	3	int:NOTO
Interaction	ERBB4 interactions	USP8 PLCG2 PTPN21 ZAP70 SH3BP2	5.46e-05	184	45	5	int:ERBB4
Interaction	SP7 interactions	LDB1 ATN1 BCL9 NIPBL PRRC2B PYGO1	5.57e-05	304	45	6	int:SP7
Interaction	CTNNB1 interactions	LRP5 USP8 GATA5 BCL9 PCBP1 MYO7A HNRNPK TP53BP2 DDR2 PYGO1	6.08e-05	1009	45	10	int:CTNNB1
Interaction	HNF1B interactions	LDB1 BCL9 PCBP1 NIPBL PRRC2B	6.36e-05	190	45	5	int:HNF1B
Interaction	CACNA1B interactions	CACNA1A CACNA1B CACNB1	7.67e-05	37	45	3	int:CACNA1B
Interaction	SSBP2 interactions	LDB1 BCL9 LMX1B PYGO1	8.80e-05	105	45	4	int:SSBP2
Interaction	SRC interactions	ANKRD11 USP8 PTPN21 MAP2K1 SH3BP2 HNRNPK DDR2 STAT6	9.76e-05	664	45	8	int:SRC
Interaction	PAX8 interactions	LDB1 BCL9 NIPBL PRRC2B	1.09e-04	111	45	4	int:PAX8
Interaction	CBLB interactions	PLCG2 ZAP70 HNRNPK DDR2	1.25e-04	115	45	4	int:CBLB
Interaction	LDB1 interactions	LDB1 BCL9 LMX1B PYGO1	1.25e-04	115	45	4	int:LDB1
Interaction	TBXT interactions	LDB1 ATN1 BCL9 NIPBL	1.29e-04	116	45	4	int:TBXT
Interaction	LAT interactions	SLC19A3 PLCG2 ZAP70 SH3BP2	1.34e-04	117	45	4	int:LAT
Interaction	ERG interactions	LDB1 BCL9 PCBP1 NIPBL PRRC2B	1.35e-04	223	45	5	int:ERG
Interaction	SSBP3 interactions	LDB1 BCL9 LMX1B PYGO1	1.43e-04	119	45	4	int:SSBP3
Interaction	RASD1 interactions	PTPN21 HNRNPK TP53BP2	1.48e-04	46	45	3	int:RASD1
Interaction	VAV1 interactions	PLCG2 MAP2K1 ZAP70 SH3BP2 HNRNPK	1.50e-04	228	45	5	int:VAV1
Interaction	PAX6 interactions	MAFB LDB1 BCL9 NIPBL PRRC2B BANP	1.54e-04	366	45	6	int:PAX6
Interaction	SCN5A interactions	CACNA1A CACNA1B BANP	1.57e-04	47	45	3	int:SCN5A
Interaction	SH3BP2 interactions	PLCG2 ZAP70 SH3BP2	1.68e-04	48	45	3	int:SH3BP2
Interaction	BCL9L interactions	LDB1 BCL9 PYGO1	1.68e-04	48	45	3	int:BCL9L
Interaction	ORC6 interactions	LDB1 BCL9 PYGO1	1.78e-04	49	45	3	int:ORC6
Interaction	PAX9 interactions	LDB1 ATN1 BCL9 NIPBL	2.01e-04	130	45	4	int:PAX9
Interaction	EYA4 interactions	LDB1 ATN1 BCL9 MAP2K1 PRRC2B	2.02e-04	243	45	5	int:EYA4
Interaction	NAA40 interactions	USP8 IRS4 AFTPH PCBP1 NIPBL PICALM HNRNPK PRRC2B TP53BP2	2.63e-04	978	45	9	int:NAA40
Interaction	CDH1 interactions	USP8 MAP2K1 PCBP1 MYO7A PICALM HNRNPK TP53BP2 DDR2	2.65e-04	768	45	8	int:CDH1
Interaction	RPL35A interactions	MAFB PPP2R5D PTPN21 MAP2K1 PCBP1 HNRNPK	2.66e-04	405	45	6	int:RPL35A
Interaction	MAGEL2 interactions	USP8 IRS4 HNRNPK	3.42e-04	61	45	3	int:MAGEL2
Interaction	RNF43 interactions	IRS4 PCBP1 PICALM HNRNPK PRRC2B TP53BP2	3.53e-04	427	45	6	int:RNF43
Interaction	GRB2 interactions	USP8 IRS4 PLCG2 ZAP70 SH3BP2 HNRNPK TP53BP2 DDR2	3.66e-04	806	45	8	int:GRB2
Interaction	IFNAR1 interactions	ZAP70 HNRNPK STAT6	3.94e-04	64	45	3	int:IFNAR1
Interaction	NALCN interactions	CACNA1A CACNA1B	4.36e-04	14	45	2	int:NALCN
Interaction	IDI2 interactions	LDB1 LMX1B	4.36e-04	14	45	2	int:IDI2
Interaction	KLF15 interactions	IRS4 BCL9 NIPBL PRRC2B BANP	4.55e-04	290	45	5	int:KLF15
Interaction	MET interactions	CACNB1 PLCG2 PCBP1 ZAP70 SH3BP2	4.55e-04	290	45	5	int:MET
Interaction	SGF29 interactions	KLF3 ATN1 TP53BP2 BANP	4.86e-04	164	45	4	int:SGF29
Interaction	SCN11A interactions	CACNA1A CACNA1B	5.03e-04	15	45	2	int:SCN11A
Interaction	MEGF6 interactions	CACNA1A ATN1	5.74e-04	16	45	2	int:MEGF6
Interaction	DHX9 interactions	PLCB1 MAFB PCBP1 NIPBL HNRNPK DDR2 STAT6	6.12e-04	662	45	7	int:DHX9
Interaction	CIC interactions	KLF3 IRS4 LDB1 PCBP1 LMX1B HNRNPK BANP	6.75e-04	673	45	7	int:CIC
Interaction	PARD6A interactions	PLCB1 PTPN21 TP53BP2	7.04e-04	78	45	3	int:PARD6A
Interaction	SLC19A3 interactions	SLC19A3 CREB3L4	7.29e-04	18	45	2	int:SLC19A3
GeneFamily	Calcium voltage-gated channel subunits	CACNA1A CACNA1B CACNB1	1.40e-05	26	33	3	253
GeneFamily	SH2 domain containing	PLCG2 ZAP70 SH3BP2 STAT6	3.31e-05	101	33	4	741
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCB1 PLCG2	5.42e-04	19	33	2	832
GeneFamily	Phospholipases	PLCB1 PLCG2	2.66e-03	42	33	2	467
GeneFamily	Basic leucine zipper proteins	MAFB CREB3L4	3.60e-03	49	33	2	506
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	PTPN21 MYO7A	3.75e-03	50	33	2	1293
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	MAFB SIGLEC1 PLCG2 GBP4 SH3BP2	1.66e-06	198	45	5	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	Influenza_Severe-gd_T\|World / Disease group and Cell class	SLC19A3 ZNF683 ZAP70 DDR2	2.10e-05	161	45	4	b3cdaed4d58d57e3c5dbc904a09388f3bf949407
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PLCB1 ZNF683 MAFB PPP2R5D	2.72e-05	172	45	4	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th1\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB1 MAP2K1 MYO7A ZAP70	2.72e-05	172	45	4	c0c9a3f5b5fb942b049bc159fd9f21b5b706edd2
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A PLCG2 DNAH12 LMX1B	2.84e-05	174	45	4	3503c7dec498597f76a86dbd5e4bb2311e743bde
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ANKRD11 PLCB1 NIPBL TP53BP2	3.85e-05	188	45	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	3.93e-05	189	45	4	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	4.01e-05	190	45	4	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	4.01e-05	190	45	4	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	4.09e-05	191	45	4	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	4.09e-05	191	45	4	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 PLCB1 GABRG3 DDR2	4.09e-05	191	45	4	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CACNA1A MAFB SIGLEC1 GBP4	4.26e-05	193	45	4	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	Children_(3_yrs)-Immune-monocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLCB1 MAFB MAP2K1 SH3BP2	4.44e-05	195	45	4	81a28289eda1a8a1a31b7357106f64ac5000e172
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CACNA1A MAFB SIGLEC1 GBP4	4.44e-05	195	45	4	9c9634906168239cf978adb398787692437bf9e7
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|COVID-19_Mild / Disease condition and Cell class	MAFB SIGLEC1 PCBP1 SH3BP2	4.53e-05	196	45	4	3729d1444c65cad640377894decc64129bc3fd5b
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	MAFB SIGLEC1 ABR MYO7A	4.53e-05	196	45	4	a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ANKRD11 KLF3 SIGLEC1 PLCG2	4.62e-05	197	45	4	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PLCB1 CACNA1A CACNA1B GABRG3	4.71e-05	198	45	4	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PLCB1 CACNA1A CACNA1B GABRG3	4.71e-05	198	45	4	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ANKRD11 KLF3 SIGLEC1 PLCG2	4.71e-05	198	45	4	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PLCB1 CACNA1A CACNA1B GABRG3	4.71e-05	198	45	4	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ANKRD11 KLF3 SIGLEC1 PLCG2	4.71e-05	198	45	4	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MAFB SIGLEC1 PLCG2 SH3BP2	4.89e-05	200	45	4	934c2efc780318c66d667ca75be0de350361d351
ToppCell	COVID-19\|World / group, cell type (main and fine annotations)	MAFB PLCG2 PCBP1 PICALM	4.89e-05	200	45	4	ac38a468559c33ee00152735ce6e408f3f48df84
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	PLCB1 CACNA1A CACNA1B GABRG3	4.89e-05	200	45	4	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANKRD11 SIGLEC1 PLCG2 NIPBL	4.89e-05	200	45	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAFB SIGLEC1 ABR MYO7A	4.89e-05	200	45	4	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ANKRD11 KLF3 PLCG2 NIPBL	4.89e-05	200	45	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A1 PLCB1 ABR DDR2	4.89e-05	200	45	4	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GABRG3 MAFB DDR2	2.25e-04	117	45	3	0602bbad908cb28c5093b74d717da5f2af577943
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAFB IRS4 PLCG2	2.36e-04	119	45	3	e868453c02dcf0e07821886b81ca739887d43c67
ToppCell	Control-Neu_0\|World / 5 Neutrophil clusters in COVID-19 patients	CACNB1 LMX1B PYGO1	2.42e-04	120	45	3	840d0ac995e2fa41996514753e4e03c4aa4a26d0
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLC19A3 GBP4 CREB3L4	3.13e-04	131	45	3	d5bc40cd585582856881081b7130dec3515b4ae0
ToppCell	NS-moderate-d_16-33-Epithelial-unknown_epithelial\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 MAFB IRS4	3.57e-04	137	45	3	03e124901a0e85b59b6882bbafab568b50907e8b
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF683 MYO7A ZAP70	3.65e-04	138	45	3	769be787e24532d5e023f99f82c7272bddac40c3
ToppCell	Endothelial-F\|World / shred on cell class and cell subclass (v4)	COL4A1 PLCB1 GBP4	3.72e-04	139	45	3	32d3c5d35e6c4205711c3500d736fd108443e6b4
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A CACNA1B GABRG3	4.47e-04	148	45	3	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A CACNA1B GABRG3	4.65e-04	150	45	3	0205318a870e091add66ee4305747dda9f51510d
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SLC19A3 KLF3 ZNF683	5.02e-04	154	45	3	ea5d0da5dd8ccfc19969aec35f044db77d589f54
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	ZNF683 PLCG2 ZAP70	5.21e-04	156	45	3	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	metastatic_Brain-T/NK_cells-Naive_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	ZNF683 PLCG2 ZAP70	5.21e-04	156	45	3	1dcb0b2d1c4b524e692d40e8403dbf7140af19b4
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A CACNA1B GABRG3	5.51e-04	159	45	3	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 PPP2R5D ZAP70	5.61e-04	160	45	3	8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB1 GATA5 STAT6	5.61e-04	160	45	3	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PLCG2 MYO7A SH3BP2	5.82e-04	162	45	3	60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed
ToppCell	E18.5-samps-Myeloid\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PLCG2 MYO7A SH3BP2	5.82e-04	162	45	3	18e4a807e25f754a69e9eaaddfde40f8de9b8512
ToppCell	E18.5-samps-Myeloid-Macrophage\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PLCG2 MYO7A SH3BP2	5.82e-04	162	45	3	0970e4eda60e3f015335e2726e6d565fb2f43372
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAFB SIGLEC1 PYGO1	6.03e-04	164	45	3	758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLCB1 CACNB1 MYO7A	6.03e-04	164	45	3	631ec9f54475dcc9d6b1c5bf6917e7fda4671034
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1A CACNA1B LMX1B	6.03e-04	164	45	3	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KLF3 MAFB DCBLD2	6.14e-04	165	45	3	d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB1 ATN1 LMX1B	6.14e-04	165	45	3	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLC19A3 GBP4 ZAP70	6.14e-04	165	45	3	7d319a112b9062efee428bef6f4534d2ce782e04
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB1 ATN1 LMX1B	6.14e-04	165	45	3	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122\|Adult / Lineage, Cell type, age group and donor	MAFB SIGLEC1 MYO7A	6.25e-04	166	45	3	be284e2e596390f05305c7bcfc316f87b963fc0b
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	PLCB1 ZNF683 PPP2R5D	6.25e-04	166	45	3	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	MUC16 GATA5 DDR2	6.25e-04	166	45	3	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A CACNA1B GABRG3	6.36e-04	167	45	3	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A SIGLEC1 SH3BP2	6.36e-04	167	45	3	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAFB GATA5 LMX1B	6.47e-04	168	45	3	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 PLCG2 MYO7A	6.47e-04	168	45	3	b4bb03efb601a61465260f93896c56861c588bef
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAFB GATA5 LMX1B	6.47e-04	168	45	3	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCB1 LRP5 MAFB	6.47e-04	168	45	3	f3b7a7df54988de77dcc7066e2fc1feb9c280b13
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 PLCG2 MYO7A	6.47e-04	168	45	3	240ea32b64d86f9216785010d6b237d9adf052c9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAFB GATA5 LMX1B	6.47e-04	168	45	3	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 PLCG2 MYO7A	6.58e-04	169	45	3	e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCB1 LRP5 MAFB	6.69e-04	170	45	3	7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1
ToppCell	Control-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	KLF3 MAFB SIGLEC1	6.69e-04	170	45	3	9e328e1f904c77dcce8aee4df775d7f0ac725775
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCB1 LRP5 MAFB	6.69e-04	170	45	3	db7cee7e518debb2cbe9eeae05d47e14b69cb8e3
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB1 MAFB MYO7A	6.81e-04	171	45	3	a474aaed3ca4cacb0ab565c35f25d92a10f531b7
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	COL4A1 PLCB1 DDR2	6.81e-04	171	45	3	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CACNB1 SIGLEC1 CREB3L4	6.81e-04	171	45	3	7c8304573b892ef9ea4e048cba9ea9fbab848dcd
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC19A3 SIGLEC1 ABR	6.92e-04	172	45	3	c8ea80042faf923b08ff03d73100533d521d73ef
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 PLCG2 MYO7A	6.92e-04	172	45	3	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL4A1 PLCB1 DDR2	7.04e-04	173	45	3	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 DDR2 PYGO1	7.16e-04	174	45	3	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 MAFB PPP2R5D	7.28e-04	175	45	3	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	Monocytes-IFN-activated_Monocytes\|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	CACNA1A ZNF683 GBP4	7.40e-04	176	45	3	6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 PLCB1 GBP4	7.40e-04	176	45	3	269326c2bf44a9003d95bc6dbc839f08f25737ca
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A DNAH12 LMX1B	7.40e-04	176	45	3	71f96cace3f20fbef975037f4deff9b82b0282a1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GATA5 ABR GBP4	7.40e-04	176	45	3	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SIGLEC1 MYO7A SH3BP2	7.40e-04	176	45	3	b0b87eebcf5c994386b39ca607e17f10e9d9de74
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	PLCB1 MAFB MYO7A	7.52e-04	177	45	3	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC19A3 GBP4 ZAP70	7.52e-04	177	45	3	fd4a297e519b3959811a462d63feebff76429031
ToppCell	droplet-Lung-nan-21m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC19A3 GBP4 ZAP70	7.52e-04	177	45	3	8cc74873f4d2d0f81042426a687b01750abc72d2
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAFB MYO7A SH3BP2	7.52e-04	177	45	3	1e7b4c0e41649d57a2c219a3b7e693538b8b34e4
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC19A3 GBP4 ZAP70	7.52e-04	177	45	3	fe0f6a73264632bdd4f9fbc22de2d155ba2bcf8c
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC19A3 GBP4 ZAP70	7.52e-04	177	45	3	e995230ef207dcd87eab4550617589016ffa9970
ToppCell	15-Airway-Immune-Hematopoietic,_Natural_Killer_Cell\|Airway / Age, Tissue, Lineage and Cell class	ZNF683 PLCG2 ZAP70	7.65e-04	178	45	3	0003c3f2561b7a1fd86772bcba59883ba1f17cd2
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD11 KLF3 GBP4	7.65e-04	178	45	3	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF683 CACNB1 ZAP70	7.90e-04	180	45	3	557453b74d4a9cc95ed1c7b9a9a58e45eb02ed6a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 GABRG3 DDR2	7.90e-04	180	45	3	280ff5c8f292be1b88120db5ff1788b750644856
ToppCell	Adult-Immune-natural_killer_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLCB1 ZNF683 ZAP70	7.90e-04	180	45	3	fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 GABRG3 DDR2	7.90e-04	180	45	3	fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB1 IRS4 ZAP70	7.90e-04	180	45	3	8cef63866c205df3825df84ce51fa61aa04ae491
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAFB DNAH12 LMX1B	7.90e-04	180	45	3	0c5d9245b8a7cc34ad52522d31559906cda55bdf
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 PLCB1 DDR2	8.02e-04	181	45	3	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNB1 PPP2R5D ZAP70	8.02e-04	181	45	3	5cecbafc29cc95896e6ccb2c74d9237b9aaece69
ToppCell	Control-Classical_Monocyte-cMono_4\|Control / Disease condition and Cell class	MAFB SIGLEC1 SH3BP2	8.02e-04	181	45	3	f3e1d8fe5cf1eba19e51c3680a55306cae687fe9
Drug	Ethylnitrosourea	COL4A1 ANKRD11 CACNA1A LRP5 PLCG2 MYO7A DCBLD2 ZAP70	9.25e-08	291	45	8	ctd:D005038
Drug	genistein	PLCB1 CACNA1A CACNA1B GABRG3 CACNB1 PLCG2 ATN1 MAP2K1 PCBP1 ZAP70 HNRNPK DDR2	1.17e-06	1117	45	12	CID005280961
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A	EML2 MAFB PTPN21 LDB1 BCL9 PRRC2B	2.54e-06	199	45	6	7170_DN
Drug	AC1L1KS5	PLCB1 CACNA1A CACNA1B CACNB1 PLCG2 ATN1 MAP2K1	3.86e-06	334	45	7	CID000005631
Drug	Verapamil	CACNA1A CACNA1B CACNB1	3.97e-06	16	45	3	DB00661
Drug	Biliverdin hydrochloride	CACNA1B MAFB SIGLEC1 ATN1 TP53BP2	1.43e-05	157	45	5	CID000000251
Drug	AC 110	CACNA1A CACNA1B	2.29e-05	4	45	2	CID000022860
Drug	papaverine	PLCB1 CACNA1A CACNA1B CACNB1 PLCG2	2.48e-05	176	45	5	CID000004680
Drug	AC1Q6T8I	PLCB1 SIGLEC1 PLCG2	2.82e-05	30	45	3	CID000000343
Drug	halothane	PLCB1 CACNA1A CACNA1B GABRG3 CACNB1 PLCG2	3.40e-05	314	45	6	CID000003562
Drug	3-aminopropylphosphinic acid	CACNA1A CACNA1B GABRG3	3.44e-05	32	45	3	CID006335948
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL4A1 PLCB1 CACNB1 PTPN21 ATN1	3.49e-05	189	45	5	4998_UP
Drug	CNS 1145	CACNA1A CACNA1B CACNB1	3.78e-05	33	45	3	CID000190902
Drug	IHC-64	CACNA1A CACNA1B CACNB1	3.78e-05	33	45	3	CID000162753
Drug	S 8510	CACNA1A CACNA1B	3.81e-05	5	45	2	CID005488383
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CACNA1A PTPN21 ATN1 SH3BP2 PRRC2B	3.86e-05	193	45	5	3262_UP
Drug	Amoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PLCB1 KLF3 EML2 PTPN21 SH3BP2	3.86e-05	193	45	5	4996_UP
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A	PLCB1 KLF3 PTPN21 LDB1 STAT6	3.95e-05	194	45	5	5263_DN
Drug	butein; Down 200; 10uM; PC3; HG-U133A	COL4A1 PLCB1 CACNB1 ABR PRRC2B	3.95e-05	194	45	5	582_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CACNA1A KLF3 EML2 DCBLD2 SH3BP2	3.95e-05	194	45	5	4169_DN
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A	KLF3 CACNB1 PTPN21 ATN1 ZAP70	4.05e-05	195	45	5	3757_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PLCG2 LDB1 BCL9 SH3BP2 STAT6	4.15e-05	196	45	5	3422_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HG-U133A	LRP5 CACNB1 ABR SH3BP2 PRRC2B	4.15e-05	196	45	5	384_UP
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A	PLCB1 CACNA1A CACNB1 DCBLD2 STAT6	4.15e-05	196	45	5	5510_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PLCB1 CACNB1 PTPN21 ATN1 LMX1B	4.15e-05	196	45	5	5011_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A	KLF3 EML2 PTPN21 ATN1 MYO7A	4.15e-05	196	45	5	4560_DN
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	KLF3 EML2 PTPN21 LDB1 BANP	4.15e-05	196	45	5	6591_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A	MAFB PTPN21 ATN1 BCL9 PICALM	4.15e-05	196	45	5	5499_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A	KLF3 PTPN21 ATN1 BCL9 SH3BP2	4.15e-05	196	45	5	4802_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PPP2R5D LDB1 PICALM SH3BP2 PRRC2B	4.15e-05	196	45	5	4815_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	KLF3 MAFB PTPN21 DCBLD2 SH3BP2	4.25e-05	197	45	5	3355_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; PC3; HT_HG-U133A	PLCB1 CACNB1 MYO7A SH3BP2 STAT6	4.25e-05	197	45	5	5759_UP
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A	CACNB1 ATN1 ZAP70 SH3BP2 STAT6	4.25e-05	197	45	5	5246_UP
Drug	Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	SLC19A3 PLCB1 IRS4 MYO7A SH3BP2	4.25e-05	197	45	5	3189_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A	PLCB1 CACNB1 PTPN21 LMX1B STAT6	4.25e-05	197	45	5	5009_UP
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	PLCB1 EML2 ATN1 SH3BP2 STAT6	4.36e-05	198	45	5	3326_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	COL4A1 PTPN21 ATN1 LMX1B SH3BP2	4.36e-05	198	45	5	3323_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A	KLF3 CACNB1 PTPN21 ATN1 SH3BP2	4.36e-05	198	45	5	6239_UP
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A	GABRG3 EML2 CACNB1 MAFB IRS4	4.36e-05	198	45	5	4158_UP
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A	PLCG2 PTPN21 ABR ATN1 PRRC2B	4.36e-05	198	45	5	5487_DN
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A	CACNA1A KLF3 PTPN21 ABR SH3BP2	4.36e-05	198	45	5	7386_UP
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	COL4A1 CACNA1A GABRG3 CACNB1 MYO7A	4.36e-05	198	45	5	4179_UP
Drug	Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A	COL4A1 MAFB IRS4 DCBLD2 SH3BP2	4.36e-05	198	45	5	3367_UP
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A	KLF3 IRS4 PTPN21 ATN1 SH3BP2	4.46e-05	199	45	5	5534_UP
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A	CACNA1A LDB1 ATN1 DCBLD2 SH3BP2	4.46e-05	199	45	5	6818_UP
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A	PLCB1 CACNB1 ATN1 SH3BP2 STAT6	4.46e-05	199	45	5	3774_UP
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; HL60; HT_HG-U133A	PLCB1 CACNA1A CACNB1 PLCG2 SH3BP2	4.46e-05	199	45	5	2144_DN
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	EML2 CACNB1 IRS4 SH3BP2 STAT6	4.57e-05	200	45	5	3935_UP
Drug	Cosopt	KLF3 MAFB GATA5 ABR LDB1 MAP2K1	5.38e-05	341	45	6	CID000003154
Drug	sevoflurane	PLCB1 GABRG3 LRP5 PLCG2	5.50e-05	105	45	4	CID000005206
Drug	SKF83742	PLCB1 PLCG2	5.70e-05	6	45	2	CID000130828
Drug	3,4-dihydroquinazoline	CACNA1A CACNA1B	5.70e-05	6	45	2	CID000583065
Drug	alpha-sialylcholesterol	CACNA1A CACNA1B	5.70e-05	6	45	2	CID000133976
Drug	APMPA	CACNA1A CACNA1B	7.97e-05	7	45	2	CID000512300
Drug	AC1NBU2S	CACNA1A CACNA1B CACNB1 MAP2K1	8.39e-05	117	45	4	CID004473765
Drug	h PM	CACNA1A CACNA1B ABR	9.66e-05	45	45	3	CID005494424
Drug	tyrphostin 25	PLCG2 MAP2K1 ZAP70 STAT6	9.86e-05	122	45	4	CID000002061
Drug	AC1L1DKK	PLCG2 MAP2K1 ZAP70 STAT6	1.15e-04	127	45	4	CID000002390
Drug	heptachlor	PLCB1 GABRG3 PLCG2 MAP2K1	1.22e-04	129	45	4	CID000003589
Drug	3-nitrocoumarin	PLCB1 PLCG2	1.70e-04	10	45	2	CID002799766
Drug	Cinildipine	CACNA1A CACNA1B CACNB1	1.86e-04	56	45	3	CID000002752
Drug	nimodipine	CACNA1A CACNA1B GABRG3 CACNB1	1.92e-04	145	45	4	CID000004497
Drug	PI(3,4,5)P3	CACNB1 PLCG2 MAP2K1 ZAP70	2.08e-04	148	45	4	CID000643963
Drug	4-aminopiperidine	CACNA1A CACNA1B	2.08e-04	11	45	2	CID000424361
Drug	leys	CACNA1A CACNA1B	2.08e-04	11	45	2	CID000484683
Drug	idebenone	CACNA1A ATN1 MAP2K1	2.17e-04	59	45	3	CID000003686
Drug	lead compounds	PLCB1 CACNA1A PLCG2 HNRNPK	2.19e-04	150	45	4	CID000073212
Drug	nilvadipine	CACNA1A CACNA1B CACNB1	2.28e-04	60	45	3	CID000004494
Drug	procaine	CACNA1A CACNA1B GABRG3 CACNB1	2.36e-04	153	45	4	CID000004914
Drug	IAA-94	CACNA1A CACNA1B CACNB1	2.40e-04	61	45	3	CID000003667
Drug	AC1NSKHI	PLCB1 PLCG2 ATN1	2.40e-04	61	45	3	CID005311358
Drug	U46619	PLCB1 CACNA1A CACNA1B CACNB1 PLCG2	2.41e-04	285	45	5	CID000005618
Drug	lindane	PLCB1 CACNA1B GABRG3 PLCG2	2.42e-04	154	45	4	CID000000727
Drug	AC1L2VU3	CACNA1A CACNA1B	2.49e-04	12	45	2	CID000129572
Drug	(4S,4aR,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-6,10,11,12-tetrahydroxy-1,3-dioxo-4a,5,5a,6,11,11a,12,12a-octahydro-4H-tetracene-2-carboxamide	PLCB1 PLCG2	2.49e-04	12	45	2	CID011840935
Drug	AC1L1II7	PLCB1 PLCG2	2.49e-04	12	45	2	CID000004589
Drug	lercanidipine	CACNA1A CACNA1B CACNB1	2.64e-04	63	45	3	CID000065866
Drug	D 609	PLCB1 PLCG2 MAP2K1	2.76e-04	64	45	3	CID000002940
Drug	mibefradil	CACNA1A CACNA1B CACNB1	2.76e-04	64	45	3	CID000060662
Drug	phenylpropane	SIGLEC1 ATN1	2.94e-04	13	45	2	CID000007668
Drug	gallopamil	CACNA1A CACNA1B CACNB1	3.16e-04	67	45	3	CID000001234
Drug	vanadyl	SIGLEC1 PLCG2 MAP2K1 MYO7A STAT6	3.39e-04	307	45	5	CID000061671
Drug	AC1L1JG6	CACNA1A CACNA1B	3.42e-04	14	45	2	CID000005026
Drug	gabapentin	CACNA1A CACNA1B GABRG3 CACNB1	3.44e-04	169	45	4	CID000003446
Drug	AC1L2AC7	CACNA1A CACNA1B CACNB1	3.45e-04	69	45	3	CID000068733
Drug	lavendustin A	CACNA1A CACNA1B CACNB1 MAP2K1	3.60e-04	171	45	4	CID000003894
Drug	vorinostat	CACNA1A CACNA1B ATN1 MAP2K1 STAT6	3.76e-04	314	45	5	CID000005311
Drug	riluzole	CACNA1A CACNA1B GABRG3 CACNB1	3.84e-04	174	45	4	CID000005070
Drug	Barium	PLCB1 CACNA1A CACNA1B	3.91e-04	72	45	3	ctd:D001464
Drug	monomethylarsonous acid	PLCB1 EML2 MAFB ATN1 MAP2K1 DCBLD2 STAT6	3.93e-04	694	45	7	ctd:C406082
Drug	butamben	CACNA1A CACNA1B	3.95e-04	15	45	2	CID000002482
Drug	CAS 298-57-7	CACNA1A CACNA1B CACNB1	4.07e-04	73	45	3	CID000002761
Drug	Cortisporin	PLCB1 CACNA1A CACNA1B PLCG2	4.10e-04	177	45	4	CID000004454
Drug	ethosuximide	CACNA1A CACNA1B CACNB1	4.24e-04	74	45	3	CID000003291
Drug	BAPTA	PLCB1 CACNA1A CACNA1B GABRG3 MAP2K1	4.33e-04	324	45	5	CID000104751
Drug	pentasulfane	CACNA1A CACNA1B	4.50e-04	16	45	2	CID000448216
Drug	Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL4A1 PLCB1 MAFB PTPN21	4.65e-04	183	45	4	7443_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	COL4A1 GABRG3 ATN1 DCBLD2	4.85e-04	185	45	4	4707_UP
Drug	Chrysamine-G	CACNA1A CACNA1B ATN1	4.95e-04	78	45	3	CID005488970
Drug	nisoldipine	CACNA1A CACNA1B CACNB1	4.95e-04	78	45	3	CID000004499
Disease	nail-patella syndrome (implicated_via_orthology)	LDB1 LMX1B	2.27e-06	2	45	2	DOID:9467 (implicated_via_orthology)
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1B	6.82e-06	3	45	2	DOID:0111181 (implicated_via_orthology)
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1B	1.36e-05	4	45	2	DOID:6364 (implicated_via_orthology)
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1B	4.75e-05	7	45	2	DOID:0050951 (implicated_via_orthology)
Disease	Hematuria	COL4A1 LMX1B	8.13e-05	9	45	2	C0018965
Disease	FEV/FEC ratio	COL4A1 ANKRD11 USP8 MAFB GATA5 DNAH12 ABR LMX1B SH3BP2	8.32e-05	1228	45	9	EFO_0004713
Disease	cyclic AMP-responsive element-binding protein 3-like protein 4 measurement	USP8 CREB3L4	1.02e-04	10	45	2	EFO_0801506
Disease	platelet component distribution width	COL4A1 PLCB1 MAFB SIGLEC1 GATA5 PLCG2 HNRNPK	1.36e-04	755	45	7	EFO_0007984
Disease	Impaired cognition	COL4A1 PICALM	2.05e-04	14	45	2	C0338656
Disease	Neurodevelopmental Disorders	ANKRD11 PPP2R5D LMX1B	3.91e-04	93	45	3	C1535926
Disease	mean platelet volume	COL4A1 ANKRD11 PLCB1 KLF3 PLCG2 MAP2K1 PICALM	8.32e-04	1020	45	7	EFO_0004584
Disease	social communication impairment	PLCB1 LMX1B	1.10e-03	32	45	2	EFO_0005427
Disease	Global developmental delay	COL4A1 CACNA1B ATN1	1.11e-03	133	45	3	C0557874
Disease	ovarian neoplasm	MUC16 BCL9 MAP2K1	1.13e-03	134	45	3	C0919267
Disease	Malignant neoplasm of ovary	MUC16 BCL9 MAP2K1	1.20e-03	137	45	3	C1140680
Disease	Autoinflammatory disorder	PLCG2 SH3BP2	1.31e-03	35	45	2	C3860213
Disease	Focal glomerulosclerosis	COL4A1 LMX1B	1.39e-03	36	45	2	C0017668

Protein segments in the cluster

Peptide	Gene	Start	Entry
TMPYIDESPTMSPQL	ABR	46	Q12979
SSYCPSEPMMSTPPP	BANP	341	Q8N9N5
DRTPLMFQRMEPPSP	CACNA1A	1981	O00555
PAASSYDSPMPPSME	ANKRD11	1816	Q6UB99
YDSPMPPSMEDRAPL	ANKRD11	1821	Q6UB99
SMSRGPYPPSQEIPM	CACNB1	6	Q02641
MEPDIIRMYSSSPPP	AFTPH	1	Q6ULP2
PTGYHAPMEPPTSRM	ATN1	191	P54259
PATPRRMSDPPLSTM	SH3BP2	271	P78314
MFRAPPPLPPVYSME	PPP2R5D	521	Q14738
VMRSGPRPIVPYSSM	CACNA1B	1116	Q00975
AVGPYIQSSTMPRMP	TP53BP2	346	Q13625
YWLSTPEPMPMSMAP	COL4A1	1521	P02462
PLSSYGMDSRPPMAI	MAP2K1	296	Q02750
TEMMITTPYVFPDVP	MUC16	10521	Q8WXI7
GRVMTIPYQPMPASS	PCBP1	176	Q15365
YPEEMSPPLMNSVSP	KLF3	211	P57682
SMGPELPTSPLAMEY	MAFB	6	Q9Y5Q3
TMLDRDVGPTPMYPP	LDB1	36	Q86U70
ALPTSPMAPTTYDPM	DDR2	376	Q16832
PPSPATDPSLYNMDM	LRP5	1501	O75197
PYLIAMGTDPEPAMR	NIPBL	2321	Q6KC79
LPPPDYPQTMTSEMK	DNAH12	76	Q6ZR08
PTPGYPESESIMMAP	GBP4	11	Q96PP9
SRMYVDPSEINPSMP	PLCG2	756	P16885
SSRMSLPKPQPYVMP	PTPN21	326	Q16825
PMFVPPARVPSMLSY	GATA5	31	Q9BWX5
YSLLDMRPPPTAMIT	GABRG3	376	Q99928
RDVPFSPDEMVPPSM	BCL9	436	O00512
PMMIPDELAPTYSLD	EML2	31	O95834
PITGPEYATPIIMDM	DCBLD2	671	Q96PD2
SMMRPSEPFLIPYLS	SLC19A3	26	Q9BZV2
PPAPRATSSPMLYEV	CREB3L4	101	Q8TEY5
RGYMMMFPRVSPPPA	IRS4	741	O14654
YSTFRMPPHVPPRMS	PYGO1	101	Q9Y3Y4
RPMPPSRRDYDDMSP	HNRNPK	271	P61978
ATMAPPVMAYPATTP	PICALM	591	Q13492
SPDKPRPMPMDTSVY	ZAP70	301	P43403
LPTPELQMPTMVPSY	STAT6	656	P42226
MMPSYMDPRITPTRT	PRRC2B	676	Q5JSZ5
YPPKTPTMMVFVEPE	SIGLEC1	1531	Q9BZZ2
LESGVPLPSPMDLMY	PLCB1	446	Q9NQ66
SPTNTVHMYPPEMAP	USP8	671	P40818
MLPQDPSYPTMAMPS	ZNF683	221	Q8IZ20
RMEGMMASYTPLAPP	LMX1B	301	O60663
SVYVMPTVTMPPREI	MYO7A	1666	Q13402